Patrick McManamny

Tel: +61 3 8618 4132


  • Melbourne

Patrick McManamny is a partner in our Melbourne biotechnology team.

He regularly counsels clients in relation to filing and management of international patent portfolios, freedom-to-operate issues, patentability and due diligence. Patrick has substantial experience in conducting due diligence in relation to biological therapeutics such as antibodies, proteins, peptides, gene therapy and cell therapies and processes for their manufacture. He also has experience in diagnostics and drug screening methods. Patrick was endorsed in the IAM Prosecution recommended list in 2022 and 2023.


Technical Group:

Read Patrick's full bio


  • Graduate Diploma in Intellectual Property Law, The University of Melbourne
  • Honours and PhD, Monash Institute of Reproduction and Development (now Hudson Institute of Medical Research)
  • Bachelor of Science in Genetics and Zoology, La Trobe University

Industry Expertise

  • Biological therapies including antibodies, peptides, fusion proteins and immunoconjugates
  • Regenerative medicine and cell therapies
  • Gene therapies
  • Manufacturing processes for biological therapies
  • Diagnostics

Professional Affiliations

  • Member - The Institute of Patent and Trade Mark Attorneys of Australia (IPTA)
  • Member - Intellectual Property Society of Australia and New Zealand (IPSANZ)
  • Member - AusBiotech